Praxis Precision Medicines, Inc.
(PRAX - NASDAQ)
332,21 USD
📋 Profilo Aziendale

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance.

|